Li and colleagues correlated the expression of lumican with prognosis in 131 untreated PC patients undergoing surgery and observed that patients with higher levels of this proteoglycan had significantly increased OS after tumor resection, as compared to those with low lumican expression levels (p = 0.0006). The gene discussed is LUM; the disease is neoplasm.